YEEDOZENCOM and Lunan Pharmaceutical Group signed a strategic cooperation agreement and will comprehensively cooperate in pharmaceutical development.

      This strategic cooperation agreement will be the starting point for Lunan Pharmaceutical Group and YEEDOZENCOM to join forces in pharmaceutical development. In the future, the two sides will cooperate in pharmaceutical R&D and innovation taking advantages of high-level R&D platforms and strong industrialization capabilities of traditional Chinese medicine, chemical and biological medicine of Lunan Pharmaceutical Group, and take advantage of YEEDOZENCOM 's extensive experience in the contract service of pharmaceutical R&D for many years. The cooperation will inject new impetus into the R&D and industrialization of Lunan Pharmaceutical Group, and help Lunan Pharmaceuticals to achieve the strategy of "taking science and technology as the guide" and the vision of "benefiting the society and creating a good life".
 

       Before the signing ceremony, YEEDOZENCOM personnel visited the R&D Laboratory and production plant of Lunan Pharmaceutical Group, and visited the Memorial Hall of Mr. Zhao Zhiquan, founder of Lunan Pharmaceutical Group, who is a "model of the times". They deeply understood the Yimeng spirit represented by Mr. Zhao Zhiquan and inherited and carried forward by Lunan Pharmaceutical Group.
 

         Mr. Zhang Guimin, Party Committee Secretary, President and General Manager of Lunan Pharmaceutical Group, and Dr. Liu Zhong, Deputy General Manager of the group, et al attended the signing ceremony.

 

        Lunan Pharmaceutical Group is a comprehensive pharmaceutical group engage in the production, R&D and sales of TCM, chemical medicine and biologics. It is a national innovative enterprise and a key high-tech enterprise under the National Torch Plan. Its member companies include Lunan Hope Pharmaceutical Co., Ltd, Lunan Better Pharmaceutical Co., Ltd., Shandong New Time Pharmaceutical Co., Ltd., Lunan New Time Bio-Tech Co., Ltd. etc. It is among the top 500 groups of China, the top 500 private manufacturer in China and the top 100 tax payer in Shandong Province for many years. 
 

      The Group has a number of high-level R&D platforms such as the National Engineering and Technology Research Center of Chiral Drugs, National Engineering Laboratory of High Level Expression in Mammalian Cells, State Key Laboratory for Generic Technology of Chinese Traditional Medicine, National Enterprise Technology Centers. The Group has technical cooperation with more than 100 universities and institutes at home and abroad. The innovation capability of the enterprise technology center is among the forefront in Chinese pharmaceutical industry. The group ranks among the top 100 Chinese innovative enterprises in 2017, and has won one second prize for national technological inventions, seven second prizes for national scientific and technological progress and the "Prize for Scientific and Technological Innovation of the Ho Leung Ho Lee Foundation" in 2018. The enterprise has established a quality assurance system in line with ICH, FDA, EDQM and other international quality management concepts. All dosage forms and products have passed the new National GMP certification and won the title of "Best Industrial Enterprise in China's Pharmaceutical R&D Product Line" for many times. The overall quality management level ranks among the top in Chinese pharmaceutical industry. The enterprise is in the leading position in the industry in terms of product quality, independent innovation ability and management level, and won the 6th Shandong Provincial Governor Quality Award.
 

About YEEDOZENCOM

 

      YEEDOZENCOM is a supplier of pharmaceutical R&D lifecycle management service with depth and warmth. On the basis of profound scientific knowledge and professional understanding of customers' products, the company is committed to proposing appropriate solutions with distinctive features. As we consider the difficulties of R&D, production, distribution and use in the whole lifecycle from the perspective of customers, the company is full of warm care in the implementation of depth-based solutions. After years of accumulation, an integrated service platform has been established and improved, which integrates project operation management, clinical research, regulatory services, biological sample analysis, data management and statistics. It aims to help pharmaceutical enterprises reduce develop time, to provide value-added technical services, so as to market products earlier.